AIFM1
Apoptosis-inducing factor 1, mitochondrial
Also known as: AIF, AIFM1_HUMAN, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95831
- Gene
- AIFM1
- Ensembl
- ENSG00000156709
- Chromosome
- X
- Canonical length
- 613 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria,Connecting piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a flavoprotein essential for nuclear disassembly in apoptotic cells, and it is found in the mitochondrial intermembrane space in healthy cells. Induction of apoptosis results in the translocation of this protein to the nucleus where it affects chromosome condensation and fragmentation. In addition, this gene product induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Mutations in this gene cause combined oxidative phosphorylation deficiency 6 (COXPD6), a severe mitochondrial encephalomyopathy, as well as Cowchock syndrome, also known as X-linked recessive Charcot-Marie-Tooth disease-4 (CMTX-4), a disorder resulting in neuropathy, and axonal and motor-sensory defects with deafness and cognitive disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 10. [provided by RefSeq, Aug 2015]
Canonical amino-acid sequenceUniProt
613 residues, UniProt reviewed canonical sequence.
>O95831|AIFM1
1 MFRCGGLAAG ALKQKLVPLV RTVCVRSPRQ RNRLPGNLFQ RWHVPLELQM TRQMASSGAS
61 GGKIDNSVLV LIVGLSTVGA GAYAYKTMKE DEKRYNERIS GLGLTPEQKQ KKAALSASEG
121 EEVPQDKAPS HVPFLLIGGG TAAFAAARSI RARDPGARVL IVSEDPELPY MRPPLSKELW
181 FSDDPNVTKT LRFKQWNGKE RSIYFQPPSF YVSAQDLPHI ENGGVAVLTG KKVVQLDVRD
241 NMVKLNDGSQ ITYEKCLIAT GGTPRSLSAI DRAGAEVKSR TTLFRKIGDF RSLEKISREV
301 KSITIIGGGF LGSELACALG RKARALGTEV IQLFPEKGNM GKILPEYLSN WTMEKVRREG
361 VKVMPNAIVQ SVGVSSGKLL IKLKDGRKVE TDHIVAAVGL EPNVELAKTG GLEIDSDFGG
421 FRVNAELQAR SNIWVAGDAA CFYDIKLGRR RVEHHDHAVV SGRLAGENMT GAAKPYWHQS
481 MFWSDLGPDV GYEAIGLVDS SLPTVGVFAK ATAQDNPKSA TEQSGTGIRS ESETESEASE
541 ITIPPSTPAV PQAPVQGEDY GKGVIFYLRD KVVVGIVLWN IFNRMPIARK IIKDGEQHED
601 LNEVAKLFNI HEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AIFM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 77 nTPM
Expression across tissuesHPA
Tissue
- liver: 77 nTPM
- heart muscle: 75 nTPM
- kidney: 69 nTPM
- skeletal muscle: 59 nTPM
- adrenal gland: 50 nTPM
- duodenum: 50 nTPM
Single-cell type
- oocytes: 134 nCPM
- hepatocytes: 112 nCPM
- parietal cells: 108 nCPM
- endometrial luminal cells: 81 nCPM
- fallopian secretory cells: 80 nCPM
- cytotrophoblasts: 80 nCPM
Immune cell
- myeloid DC: 32 nTPM
- intermediate monocyte: 27 nTPM
- non-classical monocyte: 25 nTPM
- classical monocyte: 21 nTPM
- NK-cell: 21 nTPM
- T-reg: 18 nTPM
Brain region
- choroid plexus: 38 nTPM
- thalamus: 11 nTPM
- cerebellum: 9.9 nTPM
- hypothalamus: 9.8 nTPM
- white matter: 9.3 nTPM
- pons: 9.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AIFM1.
Disease | AllUniProt
Conditions AIFM1 is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 6 (COXPD6) MIM:300816
- Charcot-Marie-Tooth disease, X-linked recessive, 4, with or without cerebellar ataxia (CMTX4) MIM:310490
- Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) MIM:300614
- Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy (SEMDHL) MIM:300232
Disease | GeneticClinVar
47 pathogenic / likely-pathogenic of 777 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deafness, X-linked 5
- Severe X-linked mitochondrial encephalomyopathy
- Combined oxidative phosphorylation deficiency
- Charcot-Marie-Tooth Neuropathy X
- Spondyloepimetaphyseal dysplasia, Bieganski type
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.49
- DepMap mean gene effect
- -0.36
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular response to aldosterone
- cellular response to estradiol stimulus
- cellular response to hydrogen peroxide
- cellular response to hypoxia
- cellular response to nitric oxide
- intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
- mitochondrial disulfide relay system
- mitochondrial respiratory chain complex assembly
- neuron differentiation
- positive regulation of apoptotic process
- positive regulation of necroptotic process
- positive regulation of neuron apoptotic process
- protein import into mitochondrial intermembrane space
- response to ischemia
- response to L-glutamate
- response to toxic substance
Molecular functions
- DNA binding
- FAD binding
- NAD(P)H oxidase H2O2-forming activity
- NADH dehydrogenase activity
- oxidoreductase activity, acting on NAD(P)H
- poly-ADP-D-ribose binding
- protein dimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FAD/NAD-linked reductase, dimerisation domain superfamily
- FAD/NAD(P)-binding domain
- FAD/NAD(P)-binding domain superfamily
- FAD-dependent Oxidoreductases and Apoptosis Regulators
- Pyridine nucleotide-disulphide oxidoreductase
- Mitochondrial apoptosis-inducing factor, C-terminal domain
- Apoptosis-inducing factor, mitochondrion-associated, C-term
KeywordsUniProt
- Acetylation
- Apoptosis
- Charcot-Marie-Tooth disease
- Cytoplasm
- Deafness
- DNA-binding
- Dwarfism
- FAD
- Flavoprotein
- Intellectual disability
- Isopeptide bond
- Membrane
- Mitochondrion
- Mitochondrion inner membrane
- NAD
- Neurodegeneration
- Neuropathy
- Nucleus
- Oxidoreductase
- Phosphoprotein
- Primary mitochondrial disease
- Transit peptide
- Ubl conjugation
InteractionsUniProt · HPA
Protein binding partners of AIFM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AIFM1 as an antibody target. Whether an autoantibody or antibody against AIFM1 could matter depends on whether native AIFM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AIFM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AIFM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...